Lifesciences
The
Circuit
Home / Feed
Insights
News
Whitepapers
Research
Events
Rankings
Jobs
Settings
Theme
Have questions, feedback, or partnership inquiries? Our team is always happy to connect and assist you.
Contact
Whatsapp
Sign In
Sign Up
Circuit Insights
Filter by Date
Loading
This may take few seconds...
The LifeSciences Circuit - Wired Into the Future of Biology
Page 1 of 1
D
Dr. Shrikant Pawar
Outsourcing Medical Device and Biomedical Product Development: A Comprehensive Guide
Outsourcing medical device and biomedical product development leverages global expertise, optimizes costs, and accelerates innovation by allowing businesses to focus on their core competencies. While concerns about IP protection and regulatory compliance are valid, these can be effectively managed through strategic partner selection, robust agreements, and clear communication. This comprehensive approach supports crucial stages from material selection and manufacturing to quality control, regulatory affairs, and ethical considerations, driving efficiency and market readiness.
IVD
Outsourcing
Medtech
Manufacturing
Design
Development
Nov 11, 2025
9 min read
0
144
1
1
P
Paritosh Dubey
Brain-Computer Interfaces Enter a New Phase: 2025 Market, Tech, and Strategy Insight
Brain-computer interfaces are transitioning from research to practical products in 2025, with non-invasive wearables now providing basic device control for accessibility and gaming. Simultaneously, advanced clinical implants are achieving significant milestones in restoring communication and movement for patients with paralysis, pushing the boundaries of what's possible in neural prosthetics. This exciting shift demands a strategic understanding of market dynamics, technological capabilities, and the opportunities for multimodal integration.
Neurology
Technology
MedicalDevices
Nov 6, 2025
9 min read
0
105
0
2
P
Paritosh Dubey
MedTech 2024: Deep Dive into Investment Trends — What Moved, What Slipped, and What It Signals
MedTech investment in 2024 presented a nuanced picture, with venture capital and M&A resurging, but a clear shift towards disciplined investment. We found capital heavily favored later-stage companies with commercialized products, propelling non-invasive monitoring and orthopedics forward while early-stage deals and certain verticals like diagnostics faced increased scrutiny. This trend underscores a rising demand for proven clinical and commercial readiness, which will continue to shape the sector's trajectory.
MedDevices
Investment
Report
Sep 23, 2025
7 min read
0
76
0
1
P
Paritosh Dubey
The FDA’s New Rules for AI Devices: What You Need to Know!
In January 2025, the U.S. FDA released landmark guidance on AI-enabled medical devices, signaling a major shift in how adaptive algorithms will be regulated. At its core is the Predetermined Change Control Plan (PCCP), allowing developers to predefine model updates while ensuring safety and transparency across the product lifecycle. The move not only provides clarity for innovators and clinicians but also builds investor confidence, marking a new era where speed, trust, and patient safety converge in digital health.
AI medical devices
digital health regulation
FDA guidance
Sep 16, 2025
5 min read
0
193
2
3
